Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 14, 2024

BUY
$0.37 - $1.69 $513,410 - $2.35 Million
1,387,595 New
1,387,595 $1.08 Million
Q3 2023

Nov 14, 2023

SELL
$0.37 - $1.69 $110,826 - $506,205
-299,530 Reduced 17.75%
1,387,595 $1.08 Million
Q2 2023

May 14, 2024

BUY
$0.39 - $1.69 $260,052 - $1.13 Million
666,800 Added 65.35%
1,687,125 $657,000
Q2 2023

Aug 14, 2023

BUY
$0.39 - $1.69 $260,052 - $1.13 Million
666,800 Added 65.35%
1,687,125 $657,000
Q1 2023

May 14, 2024

BUY
$1.75 - $3.14 $1 Million - $1.8 Million
573,803 Added 128.5%
1,020,325 $1.79 Million
Q1 2023

May 11, 2023

BUY
$1.75 - $3.14 $1 Million - $1.8 Million
573,803 Added 128.5%
1,020,325 $1.79 Million
Q4 2022

May 14, 2024

BUY
$2.09 - $4.32 $348,216 - $719,759
166,611 Added 59.52%
446,522 $1.03 Million
Q4 2022

Feb 13, 2023

BUY
$2.09 - $4.32 $348,216 - $719,759
166,611 Added 59.52%
446,522 $1.03 Million
Q3 2022

May 14, 2024

SELL
$2.24 - $4.18 $1.93 Million - $3.61 Million
-863,059 Reduced 75.51%
279,911 $764,000
Q3 2022

Nov 10, 2022

SELL
$2.24 - $4.18 $1.93 Million - $3.61 Million
-863,059 Reduced 75.51%
279,911 $764,000
Q2 2022

May 14, 2024

BUY
$2.85 - $7.77 $3.26 Million - $8.88 Million
1,142,970 New
1,142,970 $3.26 Million
Q2 2022

Aug 15, 2022

SELL
$2.85 - $7.77 $1.55 Million - $4.22 Million
-543,273 Reduced 32.22%
1,142,970 $3.26 Million
Q1 2022

May 16, 2022

BUY
$5.7 - $9.3 $2.87 Million - $4.68 Million
503,718 Added 42.6%
1,686,243 $12.8 Million
Q4 2021

Feb 14, 2022

BUY
$8.73 - $15.27 $9.02 Million - $15.8 Million
1,033,128 Added 691.53%
1,182,525 $10.3 Million
Q3 2021

Nov 10, 2021

BUY
$13.52 - $23.95 $2.02 Million - $3.58 Million
149,397 New
149,397 $2.07 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.35B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.